| Financial Year |
March 31 2023 |
| Monetary Funds |
2,226,889,734.08 |
| Held-for-trading Financial Assets |
3,558,190.09 |
| Notes Receivable |
12,179,335.00 |
| Accounts Receivable |
883,113,693.12 |
| Advances to Suppliers |
136,283,851.83 |
| Other Receivables |
10,150,673.38 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
133,086,522.60 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
29,318,741.58 |
| Total Current Assets |
3,503,223,708.64 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
788,692,450.65 |
| Investment Properties |
3,262,395.39 |
| Fixed Assetes |
4,384,291,798.90 |
| Under-construction Projects |
449,097,358.28 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
137,459,369.96 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
245,272.00 |
| Deferred Income Tax Assets |
170,327,354.00 |
| Other Non-Current Assets |
1,891,500.00 |
| Sub-Total of Non-Current Assets |
6,529,461,896.98 |
| Total Assets |
10,032,685,605.62 |
| Short-Term Loans |
80,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
1,312,387,995.21 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
179,902,126.72 |
| Taxes Payable |
214,204,410.77 |
| Interest Payable |
-- |
| Dividend Payable |
8,440,248.89 |
| Other payables |
292,482,713.15 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
59,882,489.22 |
| Other Current Liabilities |
55,797,360.60 |
| Sub-Total of Current Liabilities |
2,568,920,233.23 |
| Long-term Loans |
270,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
154,341,820.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
34,609,021.41 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
609,224,190.47 |
| Total Liabilities |
3,178,144,423.70 |
| Paid-In Capital(Or Share Stock) |
1,146,502,523.00 |
| Capital Surplus |
1,309,940,189.86 |
| Surplus Reserve |
367,834,720.28 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
4,024,859,245.21 |
| Minority Stockholder's Interest |
-34,112,295.33 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,888,653,477.25 |
| Owner's Equity（Stockholder's Equity） |
6,854,541,181.92 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
10,032,685,605.62 |
